Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Blogs
»
Drug Injury Watch: Teva's Budeprion XL Will Get Another Safety And Efficacy Review By FDA
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
2
Vote
Drug Injury Watch: Teva's Budeprion XL Will Get Another Safety And Efficacy Review By FDA
Posted by
tjlpa
72 days ago
(
http://www.drug-injury.com
)
View profile
Category
:
Blogs
|
Tags
:
fda
drug-safety
drug-injury
generics
FDA To Collaborate With Complaining Patients On Study Of Reported Problems With This Generic Version Of Antidepressant Wellbutrin XL
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
tjlpa
worldpharmanews
Related Links
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
FDA says toxicology studies for lead drug invalid
FDA Links Anti-Wrinkle Drugs to Deaths - Forbes.com
FDA Notifies Public of Adverse Reactions Linked to Botox Use
Pharmalot » Lilly's Prasugrel Denied FDA Priority Review?
Courageous Sanity Triumphs Over Political Inanity (DrugWonks)
FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992
Trasylol® - One Thousand Lives A Month
Drug Injury Watch: Dr. Dennis Mangano Says On 60 Minutes In February 2008 That Trasylol Should Have Been Recalled As Early As January 2006
Drug Injury Watch: FDA's Proposed Rule About Drug Label Warning Changes Will Lessen Its Power To Protect Us
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
1
Children in the world's poores...
Published News
1
Children in the world's poores...
2
Drug Injury Watch: Risk Of Dig...
1
New discovery: lethal fungus r...
2
UnitedHealth Takes On Microsof...
2
Goodwin: Pharma Ties Have 'Nev...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
bayer
biotech
drug-injury
drug-safety
fda
glaxosmithkline
novartis
pfizer
pharma
training courses
read more
Comments